Although there were statistically highly significant differences in vaccine challenge responses between patients accepted for SCIG/IVIG vs hypogammaglobulinemia patients who were not, there was considerable overlap in results.
← all excerpts
Common Variable Immunodeficiency Disorders: A perspective from New Zealand.
1
—
—